Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse

Little is known about optimally applying chemotherapeutic agents in a specific temporal sequence to rapidly reduce the tumor load and to improve therapeutic efficacy. The clinical optimization of drug efficacy while reducing side effects is still restricted due to an incomplete understanding of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gladbach, Yvonne Saara, Sklarz, Lisa-Madeleine, Roolf, Catrin, Beck, Julia, Schütz, Ekkehard, Fuellen, Georg, Junghanss, Christian, Murua Escobar, Hugo, Hamed, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316692/
https://www.ncbi.nlm.nih.gov/pubmed/35886023
http://dx.doi.org/10.3390/genes13071240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316692/
https://www.ncbi.nlm.nih.gov/pubmed/35886023
http://dx.doi.org/10.3390/genes13071240

Ejemplares similares